Explore
Validate
LearnALX-804-708-C050
antibody from Enzo Life Sciences
Targeting: FOXP3
AIID, DIETER, IPEX, JM2, PIDX, SCURFIN, XPID
Western blot
ELISA
ImmunocytochemistryAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Immunocytochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ALX-804-708-C050 - Provider product page
- Provider
- Enzo Life Sciences
- Proper citation
- Enzo Life Sciences Cat#ALX-804-708-C050, RRID:AB_2051427
- Product name
- FOXP3 (mouse) monoclonal antibody (MF333F)
- Antibody type
- Monoclonal
- Antigen
- Recombinant full length protein
- Reactivity
- Mouse
- Host
- Rat
- Isotype
- IgG
- Antibody clone number
- MF333F
- Vial size
- 50 μg
- Storage
- -20°C
- Handling
- Avoid freeze/thaw cycles. After opening, prepare aliquots and store at -20¡C.
Submitted references Dendritic cells expressing transgenic galectin-1 delay onset of autoimmune diabetes in mice.
"Alternatively activated" dendritic cells preferentially secrete IL-10, expand Foxp3+CD4+ T cells, and induce long-term organ allograft survival in combination with CTLA4-Ig.
Regulated compartmentalization of programmed cell death-1 discriminates CD4+CD25+ resting regulatory T cells from activated T cells.
Immunosurveillance of Erbb2 carcinogenesis in transgenic mice is concealed by a dominant regulatory T-cell self-tolerance.
Perone MJ, Bertera S, Tawadrous ZS, Shufesky WJ, Piganelli JD, Baum LG, Trucco M, Morelli AE
Journal of immunology (Baltimore, Md. : 1950) 2006 Oct 15;177(8):5278-89
Journal of immunology (Baltimore, Md. : 1950) 2006 Oct 15;177(8):5278-89
"Alternatively activated" dendritic cells preferentially secrete IL-10, expand Foxp3+CD4+ T cells, and induce long-term organ allograft survival in combination with CTLA4-Ig.
Lan YY, Wang Z, Raimondi G, Wu W, Colvin BL, de Creus A, Thomson AW
Journal of immunology (Baltimore, Md. : 1950) 2006 Nov 1;177(9):5868-77
Journal of immunology (Baltimore, Md. : 1950) 2006 Nov 1;177(9):5868-77
Regulated compartmentalization of programmed cell death-1 discriminates CD4+CD25+ resting regulatory T cells from activated T cells.
Raimondi G, Shufesky WJ, Tokita D, Morelli AE, Thomson AW
Journal of immunology (Baltimore, Md. : 1950) 2006 Mar 1;176(5):2808-16
Journal of immunology (Baltimore, Md. : 1950) 2006 Mar 1;176(5):2808-16
Immunosurveillance of Erbb2 carcinogenesis in transgenic mice is concealed by a dominant regulatory T-cell self-tolerance.
Ambrosino E, Spadaro M, Iezzi M, Curcio C, Forni G, Musiani P, Wei WZ, Cavallo F
Cancer research 2006 Aug 1;66(15):7734-40
Cancer research 2006 Aug 1;66(15):7734-40
No comments: Submit comment
Supportive validation
- Submitted by
- Enzo Life Sciences (provider)
- Main image
- Experimental details
- Western blot analysis of mouse FOXP3 with MAb to FOXP3 (mouse) (MF333F) (Prod. No. ALX-804-708) at 1:2'000. 1. Recombinant mouse FOXP3 protein (His tagged). 2. Transfected mouse FOXP3 full length cell lysate (HEK 293). 3. Mouse T lymphocyte (CD4+) cell lysate.4. PHA treated mouse T cell (CD4+) lysate.
- Submitted by
- Enzo Life Sciences (provider)
- Main image
- Experimental details
- Immunofluorescent imaging of activated mouse CD4+ T cells with MAb to FOXP3 (mouse) (MF333F) (Prod. No. ALX-804-708) which recognizes mouse FOXP3 in the nucleus.
